UPDATE 3-Valeant outlines asset sale plan to cut debt, stock jumps

Aug 9 (Reuters) - Valeant Pharmaceuticals International Inc

will sell billions of dollars in assets to pay

down debt and focus on businesses like dermatology and Bausch &

Lomb eyecare, the Canadian drug maker said on Tuesday, driving

its shares up 13 percent.

Read more